Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
1. 1-(beta-(4''-chlorobenzylthio)-2'4'-dichlorophenethyl)imidazole
2. Exelderm
3. Myk
4. Sulconazole
5. Sulconazole Mononitrate
6. Sulconazole, Mononitrate, (+-)-isomer
1. 61318-91-0
2. Exelderm
3. 82382-23-8
4. Sulconazole Nitrate Salt
5. 1-[2-(4-chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1h-imidazole Nitrate
6. Sulconazolenitrate
7. Sulconazole (mononitrate)
8. Sulcosyn
9. Rs 44872
10. Rs-44872
11. Sulconazole (nitrate)
12. 1-(2-((4-chlorobenzyl)thio)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
13. Nsc-757849
14. Rs-44872-00-10-3
15. 1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric Acid
16. Mls000028611
17. (+/-)-sulconazole (nitrate)
18. (+/-)-sulconazole (mononitrate)
19. 1-(2-[p-chlorobenzylthio]-2-[2,4-dichlorophenyl]ethyl)-1h-imidazole
20. Sulconazole Mononitrate
21. 1t89100d5u
22. 61318-91-0 (nitrate)
23. Smr000058734
24. Dsstox_cid_25490
25. Dsstox_rid_80911
26. Dsstox_gsid_45490
27. Sulconazle Nitrate
28. Sr-01000000237
29. Unii-1t89100d5u
30. 1-(2-(4-chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole Nitrate
31. Exelderm (tn)
32. Prestwick_128
33. Mfcd00058163
34. Sulconazole Nitrate [usan:usp:jan]
35. Opera_id_1591
36. Ncgc00016898-01
37. (+-)-1-(2,4-dichloro-beta-((4-chlorobenzyl)thio)phenethyl)imidazole Nitrate
38. Sulconazole Nitrate (1:x)
39. Sulconazolenitratesalt
40. Cas-61318-91-0
41. (+-)-1-(2,4-dichloro-beta-((p-chlorobenzyl)thio)phenethyl)imidazole Mononitrate
42. Schembl36906
43. Mls001146948
44. Mls002222171
45. Spectrum1501148
46. Chebi:9326
47. Sulconazole Nitrate (jan/usp)
48. Chembl1200348
49. Dtxsid2045490
50. Sulconazole Nitrate [mi]
51. Hms500k22
52. Sulconazole Nitrate [jan]
53. Hms1570b21
54. Hms1921l03
55. Hms2092h09
56. Hms2097b21
57. Hms2232b18
58. Hms3370h17
59. Hms3652c18
60. Hms3714b21
61. Pharmakon1600-01501148
62. Sulconazole Nitrate [usan]
63. Sulconazole Nitrate [vandf]
64. Bcp15962
65. Hy-b1460
66. Sulconazole Nitrate [mart.]
67. Tox21_110671
68. Ccg-39015
69. Nsc757849
70. S4120
71. Sulconazole Nitrate [usp-rs]
72. Sulconazole Nitrate [who-dd]
73. Akos015897482
74. Tox21_110671_1
75. Ks-1471
76. Nsc 757849
77. 1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole; Nitric Acid
78. Ncgc00018250-06
79. Ncgc00094911-01
80. Ncgc00094911-02
81. Ncgc00094911-03
82. Ncgc00094911-04
83. Sulconazole Nitrate [orange Book]
84. 1h-imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-, Mononitrate, (+-)-
85. 1h-imidazole, 1-[2-[[(4-chlorophenyl)methyl]thio]-2-(2,4-dichlorophenyl)ethyl]-, Nitrate (9ci)
86. Ac-26451
87. Sulconazole Nitrate [usp Monograph]
88. Cs-0013167
89. Ft-0659334
90. Sw196439-3
91. U0112
92. D00886
93. Rs-44872-00-1o-3
94. A833159
95. A916203
96. Sr-01000000237-2
97. Sr-01000000237-4
98. Q27252867
99. (+/-)-1-(2,4-dichloro-.beta.-((p-chlorobenzyl)thio)phenethyl)imidazole Mononitrate
100. 1-[2-[(4-chlorophenyl)methylthio]-2-(2,4-dichlorophenyl)ethyl]imidazole; Nitric Acid
101. 1h-imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-, Mononitrate, (+/-)-
102. 1h-imidazole, 1-[2-[[(4-chlorophenyl)methyl]thio]-2-(2,4-dichlorophenyl)ethyl]-, Nitrate (1:1)
Molecular Weight | 460.8 g/mol |
---|---|
Molecular Formula | C18H16Cl3N3O3S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 458.997796 g/mol |
Monoisotopic Mass | 458.997796 g/mol |
Topological Polar Surface Area | 109 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 404 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Exelderm |
PubMed Health | Sulconazole (Topical route) |
Drug Classes | Antifungal, Imidazole |
Drug Label | EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is a broad-spectrum antifungal agent intended for topical application. Sulconazole nitrate, USP the active ingredient in EXELDERM CREAM, is an imidazole derivative with in vitro antifungal and antiyeast... |
Active Ingredient | Sulconazole nitrate |
Dosage Form | Cream; Solution |
Route | Topical |
Strength | 1% |
Market Status | Prescription |
Company | Ranbaxy |
2 of 2 | |
---|---|
Drug Name | Exelderm |
PubMed Health | Sulconazole (Topical route) |
Drug Classes | Antifungal, Imidazole |
Drug Label | EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is a broad-spectrum antifungal agent intended for topical application. Sulconazole nitrate, USP the active ingredient in EXELDERM CREAM, is an imidazole derivative with in vitro antifungal and antiyeast... |
Active Ingredient | Sulconazole nitrate |
Dosage Form | Cream; Solution |
Route | Topical |
Strength | 1% |
Market Status | Prescription |
Company | Ranbaxy |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sulconazole Nitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulconazole Nitrate, including repackagers and relabelers. The FDA regulates Sulconazole Nitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulconazole Nitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sulconazole Nitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sulconazole Nitrate supplier is an individual or a company that provides Sulconazole Nitrate active pharmaceutical ingredient (API) or Sulconazole Nitrate finished formulations upon request. The Sulconazole Nitrate suppliers may include Sulconazole Nitrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sulconazole Nitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sulconazole Nitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sulconazole Nitrate active pharmaceutical ingredient (API) in detail. Different forms of Sulconazole Nitrate DMFs exist exist since differing nations have different regulations, such as Sulconazole Nitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sulconazole Nitrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sulconazole Nitrate USDMF includes data on Sulconazole Nitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sulconazole Nitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sulconazole Nitrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sulconazole Nitrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sulconazole Nitrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sulconazole Nitrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sulconazole Nitrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sulconazole Nitrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sulconazole Nitrate suppliers with NDC on PharmaCompass.
Sulconazole Nitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulconazole Nitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulconazole Nitrate GMP manufacturer or Sulconazole Nitrate GMP API supplier for your needs.
A Sulconazole Nitrate CoA (Certificate of Analysis) is a formal document that attests to Sulconazole Nitrate's compliance with Sulconazole Nitrate specifications and serves as a tool for batch-level quality control.
Sulconazole Nitrate CoA mostly includes findings from lab analyses of a specific batch. For each Sulconazole Nitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulconazole Nitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulconazole Nitrate EP), Sulconazole Nitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulconazole Nitrate USP).
LOOKING FOR A SUPPLIER?